Skip to main content

European Society for Magnetic Resonance in Medicine and Biology

Full day workshop
Chair
: Mathieu D . Santin (FR)
Committee: Andreea Hertanu (FR), Markus Aswendt (DE), Alkystis Phinikaridou (UK)

Full day workshop
Chairs: Chantal Tax (NL & UK), Mariam Andersson (DK)
Committee: Elda Fischi-Gómez (CH), Emma Thomson (DK), Maëliss Jallais (UK), Isabelle Corouge (FR)

This whole-day workshop will provide a structured overview of state-of-the-art microstructure imaging, integrating physical foundations, methodological innovation, and complementary validation strategies, aiming to support interaction between communities that may otherwise operate separately. The target audience includes researchers, clinician-scientists, engineers, and trainees working in or entering the field of microstructure imaging. 

Microstructure imaging is among the most rapidly advancing domains in magnetic resonance research, enabling increasingly specific insights into tissue architecture and pathological alterations. Despite these advances, important challenges persist regarding model assumptions, biological specificity, and cross-modal validation. 

The workshop will open with an interactive session on the physics of diffusion in microstructure, introducing propagator formalism and diffusion encoding strategies. The second session will focus on multi-contrast microstructure MRI, including diffusion–relaxation methods, low-field relaxometry, and diffusion-QSM, emphasising how integrated contrasts enhance sensitivity to specific microstructural features. The third session will broaden the perspective of microstructure imaging beyond MRI, incorporating talks on advanced microscopy and ultrasound approaches by leading researchers within their respective fields, followed by a panel discussion. The final session will highlight emerging directions, including within-cell MRI and organoid-based microstructure imaging, and will introduce a proposed community-wide microstructure imaging challenge designed to stimulate methodological benchmarking and development, as well as collaborative discussion.

Abstract presenters will be invited to deliver short pitches, complemented by dedicated poster-viewing sessions.

Organizers

Allison McGee,
University College Dublin
allison.mcgee@ucd.ie

Claude Portanier,
Mater Dei Hospital, Malta
claude.portanier-mifsud@gov.mt

Duration

Half day in the morning from 09:00 to 12:30

Target audience

This session will be of interest to the MRI community, including researchers, medical physicists, clinicians and radiographers.

Session Schedule

Please see below the proposed schedule with speaker names for those who have agreed to contribute if this pre-congress session is approved by the CPC.

09:00 Workshop Introduction (Allison McGee, Ireland)

09:10 ESMRMB practice guidelines when managing MR safety in vulnerable patients (Francesco Santini, Basel)

09:40 Safety considerations for remote MRI (Tomasz Bienias, Germany)

10:10 Safety considerations in paediatric MRI (Fernaiza Sahidjuan, GOSH London)

10:40 Q&A session 1

10:55 Coffee Break

11:15 MR scanning protocol optimisation for MR conditional implants (Claude Portanier Mifsud, Malta)

11:45 Considerations and processes for hearing implant MRI testing (Markus Nagl, Med-EL Medical Electronics Austria)

12:15 Q&A session 2

12:30 Close

Half-day workshop

Chair: Sonia Waiczies (DE)
Committee: Ismail Koubiyr (NL), Myrte Strik (NL) 

Annual Meeting of the Working Group on Multiple Sclerosis and Related Neuroimmunological Disorders: Translating Clinical Needs into Robust MR Solutions

This meeting focuses on how advanced MRI can support diagnosis, prognostics, and therapy monitoring in MS, with translational extension to related autoimmune CNS diseases such as NMOSD and MOGAD. We aim to bring together MR physicists, imaging scientists, neurologists, neuroradiologists, and industry stakeholders, fostering exchange between clinical needs, biomarker development, and implementation. 

Session 1: Optic Nerve

13:30 – 14:15

Olivier Outteryck, Université de Lille, FR – Bringing Optic Nerve MRI to the Foreground: a Clinical Perspective

Deborah Pareto, Vall d’Hebron University Hospital, ES  – Bringing the Optic Nerve into Focus: Technical and Quantitative MRI in MS

Session 2: MR Lesion Biomarkers

14:15 – 15:00

Alessandro Cagol, University of Basel, CH – Paramagnetic Rim Lesions and Slowly Expanding Lesions in MS: from MRI Biomarkers to Clinical Impact

Meritxell Bach Cuadra, Lausanne University, CH – Paramagnetic Rim Lesions and Slowly Expanding Lesions in MS: from MRI Acquisition 

to Automated Detection

Break

15:00 – 15:30

Power pitch presentations of selected abstracts 

15:30 – 16:00

Session 3: Patient Trajectories and Prognosis

16:00 – 16:45

Carmen Tur, Vall d’Hebron University Hospital, ES – Understanding and Predicting Progression in MS

Loredana Storelli, IRCCS San Raffaele Scientific Institute, IT – Patient Trajectories and Prognosis in Neuroimmunological Disorders: A Technical Perspective on MRI-Based Modeling

Session 4: MRI in Clinical and Research Settings

16:45 – 17:30

Pablo Naval Baudín, Bellvitge University Hospital, ES – MRI Acquisition in MS: the Clinical Perspective

José P. Marques, Radboud University, NL – Quantitative MR in MS: the Proven and the New Kids on the Block – a Means to Study Lesions and Normal-Appearing Tissue

Round table discussion and WG Meeting

17:30 – 18:00

Annual Meeting of the Glioma MRI (GliMR) Working Group       

The Glioma MRI community invites you to join the GliMR 2026 Pre-Day Meeting to discuss the current state and future directions of brain tumor MRI. The meeting will span clinical practice to translational neuro-oncology imaging, with a strong emphasis on trainees and early-career researchers. It will also actively engage industry partners and patient representatives, ensuring that all key stakeholders in brain tumour imaging are represented.

The event is tailored for trainees, early- and senior-career researchers, radiographers, and clinicians with a primary interest in brain tumour imaging, encompassing diverse backgrounds such as neuroimaging and data science, neuroradiology, neurosurgery, and preclinical/basic research in glioma models. The programme is structured into five sessions designed to promote knowledge exchange, highlight recent scientific and technological advances, and critically assess current challenges while identifying future directions in glioma MRI, in collaboration with industry and patient representatives.

To participate, please register for the Pre-Day Meeting: REGISTRATION

Important announcements:

  • A call for networking projects (including ongoing initiatives and new proposals) is open until  11 September – extended deadline! Applications can be submitted here.
  • Travel stipends are available for trainees, early-career researchers, radiographers, and clinicians (see details below). Applications must be submitted by 15 July 2026 using this application form.

Program

Time

Sessions

Moderators / Speakers

08:50-09:00

Welcome

Esther Warnert, Rui Simoes

09:00-10:30

S1. Improve patient outcomes with brain tumor imaging

 Vera Keil, Thomas Booth

09:00-09:20

Treatment planning and monitoring: seeing more, seeing better

Cristina Ramos, Porto PT

09:20-09:40

Improving neurosurgery with imaging and music

Andreu Gabarros, Barcelona ES

09:40-10:00

Non-invasive imaging and patient quality of life

The Brain Tumor Charity, Fleet UK

10:00-10:30

Round Table Discussion

All Session Speakers

10:30-11:00

COFFEE BREAK

 

11:00-12:30

S2. Translational frontiers for brain tumor imaging

Ana P Candiota, Harish Poptani

11:00-11:30

Imaging brain tumor microstructural remodeling

Marco Palombo, Cardiff UK

11:30-12:00

AI-enhanced glioma MRI in neuroscience and neuroradiology

Esin Ozturk, Istanbul TR

12:00-12:30

Linking brain tumor imaging and histology

Peter LaViolette, Milwaukee WI USA

12:30-13:30

LUNCH

 

12:30-13:30

S3. Sponsored Session: Lunch Symposium

 Ana Matoso, Rui Simoes

13:45-17:45

S4 GliMR: where we stand and new challenges

 Yaara Erez, Jan Petr

13:45-14:00

Present and future of GliMR

Esther Warnert, Rotterdam NL

14:00-14:20

The Current Histomolecular Classification of Gliomas: WHO 2026 and Beyond

Cristina Carrato, Badalona ES

14:20-14:40

Cancer Imaging Europe (EUCAIM): Glioblastoma

Maria Beser Robles, Valencia ES

14:40-15:10

COFFEE BREAK

 

15:10-16:10

Selected abstract presentations [LIST BELOW]

(ESMRMB abstracts submitted)

16:10-17:10

Selected project presentations

(GliMR networking initiatives submitted)

17:10-17:50

S5. Task Forces

(breakout session)

17:50-18:00

Adjourn

Esther Warnert, Rui Simoes

Abstract presentations

Title

Presenter

Program Number

A neural network approach for efficient magnetic resonance vascular fingerprinting using spin- and gradient-echo dynamic susceptibility contrast MRI

Karen van der Werff

P361

Taking a new angle to map microstructural collapse and occult pathology in brain tumors using orientation-dependent NODDI

Melanie Bauer

P234

Two immunometabolic worlds in high-grade gliomas: interaction between immune checkpoints and tumor metabolism.

Paula Carretero Navarro

P276

Automated classification of glioma treatment response: benchmarking via modality selection and coarse tumor detection

Ana Matoso

PG183

Feasibility of Tumor-Masked Structural Connectomics and Explainable Machine Learning for Assessing White Matter Disruption in Gliomas: A Pilot Study

Montalba Cristian

PG185

Automated enhancing tumour extraction via T1c image subtraction: A radiomic comparison against expert delineation in post-treatment Glioma

Akashleena Chatterjee

P399

Cross-modality radiomic biomarker consistency in glioma: Comparing LASSO-selected features from DCE-MRI pharmacokinetic maps and structural MRI

Akashleena Chatterjee

P398

A Continuous Learning Strategy for Automated Glioblastoma Segmentation: Knowledge Transfer between Pre-Operative and Post-Operative MRI Data

Catarina Passarinho

PG186

Perfusion-Discordant Hypoxia-BOLD Hotspots in the Non-Enhancing Glioblastoma Margin: Voxelwise DSC Regression and Biopsy Validation

Tristan Schmidlechner

P265

Can Uncertainty Quantification Improve Trust in AI-assisted Clinical Decision-making? A Case Study in MRI-based Glioma Subtyping

Gonzalo Esteban Mosquera Rojas

P403

Correlation of BBB-ASL Exchange Time with DCE-MRI Derived Permeability Parameters in Gliomas

Gülce Turhan

PG074

Harnessing 3 Tesla MRI for in vivo microstructural characterization of the glioblastoma microenvironment in patient-derived mouse models

Joao F Zamith

PG169

Comparison of T2 values estimated from Multi-TE M0 and Arterial Spin Labeling MRI

Ayse Irem Cetin

P334

Travel Stipends

1. Regulations

Travel Stipends generously supported by The Brain Tumour Charity.

Article 1 – Purpose

The GliMR 2026 Pre-Day Meeting will award ten (10) Travel Stipends to support the participation of trainees attending the meeting in Girona, Spain, on 30 September 2026.

Article 2 – Value of the Stipend

  1. Each Travel Stipend has a value of €150 (one hundred and fifty euros).
  2. The Travel Stipends are funded through the support of The Brain Tumour Charity.
  3. The stipend will be paid to the selected applicants following the procedures defined by the Organizing Committee, which will request awardees to provide their IBAN account details for bank transfer payment the week following the meeting.

Article 3 – Eligibility

Applicants must: (a) be students, doctoral candidates, postdoctoral researchers, residents, fellows, or other trainees; (b) have no more than eight (8) years of research or clinical experience following completion of their PhD degree (justified career breaks will be considered); and (c) submit a statement of no more than 100 words describing why they wish to attend the GliMR 2026 Pre-Day Meeting and what they expect to gain from participation. Priority will be given to first/presenting authors of submitted work (GliMR-selected ESMRMB abstracts and/or project call) to the GliMR pre-day meeting, which should be specified in the application.

Article 4 – Evaluation Criteria

Applications will be evaluated independently by the Jury according to: Relevance of the statement (0–5 points) and Expected impact of attendance on the applicant’s training and career development (0–5 points). Maximum score: 10 points.

Article 5 – Selection Procedure

  1. Applications will be ranked according to their total score.
  2. The ten (10) highest-scoring applicants will receive a Travel Stipend, conditional on attending the GliMR 2026 Pre-Day meeting.
  3. In the event of a tie affecting the final positions, the Jury will reach a consensus decision.
  4. The Jury reserves the right not to award all stipends if the quality of applications is deemed insufficient.

Article 6 – Jury

The Jury shall consist of the Organizing Committee of the GliMR 2026 Pre-Day Meeting:

Rui Simões (Porto, Portugal)
Esther Warnert (Rotterdam, Netherlands)
Ana Paula Candiota (Barcelona, Spain)
Harish Poptani (Liverpool, United Kingdom)
Yaara Erez (Ramat Gan, Israel)
Ana Matoso (Lisbon, Portugal)
Albert Pons-Escoda (Barcelona, Spain)

The Jury’s decisions are final and not subject to appeal.

Article 7 – Final Provisions

  1. Any matters not covered by the present Regulations shall be decided by the Jury.
  2. Applications must be submitted online by 15 July 2026 via this form.
  3. The recipients of the Travel Stipends will be announced on this webpage by 31 July 2026 and formally recognized during the GliMR 2026 Pre-Day Meeting by a member of the Jury.
  4. These Regulations enter into force on the date of their publication.

2. Recipients

  • Catarina Passarinho
    Instituto Superior Técnico, Lisbon, Portugal
  • Gonzalo Esteban Mosquera Rojas
    Erasmus MC, Rotterdam, Netherlands
  • Gülce Turhan
    Boğaziçi University, Istanbul, Türkiye
  • Harshit Harshit
    Université Toulouse, Toulouse, France
  • João Zamith
    i3S – Instituto de Investigação e Inovação em Saúde, Porto, Portugal
  • Karen van der Werff
    Erasmus MC, Rotterdam, Netherlands
  • Lobke Mesdagh
    Ghent University, Ghent, Belgium
  • Marta Padrela Loureiro
    Instituto Superior Técnico, Lisbon, Portugal
  • Yıldız Tüzün
    Boğaziçi University, Istanbul, Türkiye

3. Addendum

As only 9 of the 10 available travel stipends were awarded, the funds from the unawarded stipend (€150) have been redistributed equally among the recipients, increasing each travel stipend to €166.

Half-day workshop
Chair: Lars E. Olsson (SE)
Committee: Marielle Philippens (NL), Marco Riboldi (DE), Joan Chick (UK)

Programme

13:30 – 14:00 Introduction and motivation – Why MRI in RT – Lars E. Olsson – Lund University, Lund SE

14:00 – 14:30 Differences between diagnostic MRI-physics and MRI-physics in RT-applications – Marco Riboldi, Ludwig-Maximilians-Universität, Munich DE

14:30 – 15:00 MRI in RT – workflow, coils, protocols…  – Joan Chick – ICR Royal Marden, London UK

15:00 – 15:30 MRI-only RT – Hubert Gabrys – University Hospital, Zurich CH

15:30 – 16:00 Break

16:00 – 16:30 Specific MRI QA in RT – Marielle Philippens – University Medical Center, Utrecht NL

16:30 – 17:00 Functional MRI and imaging biomarkers – Petra van Houdt -NKI, Amsterdam, NL

17:00 – 17:30 MR-guided RT, MR-linac – Bas Raaymakers – University Medical Center, Utrecht NL

17:30 – 18:00 Discussion: The Expanding Role of MRI in Radiotherapy – A Panel of Speakers

 

Large international conferences can be overwhelming for newcomers, particularly for those attending alone.

“Magnetic North: Your Guide to Navigating ESMRMB” is a full-day pre-congress event designed to support first-time and early-career attendees by providing a structured and low-pressure introduction to the ESMRMB Annual Meeting. The programme combines practical guidance on navigating the conference with interactive activities aimed at fostering early connections among participants. Sessions include a practical introduction to the structure of the ESMRMB meeting, senior researchers sharing personal conference experiences, guided networking activities, and a soft skill development workshop about pitching science.